Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Or

Showing results (231-240 of 256) with videos related to

Pageof 26
Sort By:
Bone Marrow Transplantation|July 6, 2004
Low transplant-related mortality with allogeneic stem cell transplantation in elderly patientsM Y Shapira, I B Resnick, M Bitan, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 10, 1998
Allogeneic cell-mediated and cytokine-activated immunotherapy for malignant lymphoma at the stage of minimal residual disease after autologous stem cell transplantationR Or, A Ackerstein, A Nagler, et al.
Bone Marrow Transplantation|September 4, 2003
A new minimally ablative stem cell transplantation procedure in high-risk patients not eligible for nonmyeloablative allogeneic bone marrow transplantationM Y Shapira, R Or, I B Resnick, et al.
Clinical Transplantation|April 28, 2004
Tube thoracostomy during allogeneic stem cell transplantation does not carry an increased risk for infections or bleedingD Barkan, S Nusair, I B Resnick, et al.
Bone Marrow Transplantation|December 1, 2009
The number of infused CD34+ cells does not influence the incidence of GVHD or the outcome of allogeneic PBSC transplantation, using reduced-intensity conditioning and antithymocyte globulinP Tsirigotis, M Y Shapira, R Or, et al.
Bone Marrow Transplantation|April 3, 2001
Lack of known hepatitis virus in hepatitis-associated aplastic anemia and outcome after bone marrow transplantationR Safadi, R Or, Y Ilan, et al.
Bone Marrow Transplantation|March 7, 2006
A prospective, double-blind phase II study evaluating the safety and efficacy of a topical histamine gel for the prophylaxis of oral mucositis in patients post hematopoietic stem cell transplantationS Elad, A Ackerstein, M Bitan, et al.
Bone Marrow Transplantation|June 9, 2009
Quantitative monitoring of multi-donor chimerism: a systematic, validated framework for routine analysisD Kristt, B Gesundheit, J Stein, et al.
Acta Haematologica|March 7, 1998
Use of fiberoptic bronchoscopy in bone marrow transplant recipientsM Glazer, R Breuer, N Berkman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 13, 2006
Safety and efficacy of donor lymphocyte infusions following mismatched stem cell transplantationR Or, E Hadar, M Bitan, et al.
Pageof 26

Showing results (231-240 of 256) with videos related to

Sort By:
Pageof 26
Bone Marrow Transplantation|July 6, 2004
Low transplant-related mortality with allogeneic stem cell transplantation in elderly patientsM Y Shapira, I B Resnick, M Bitan, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 10, 1998
Allogeneic cell-mediated and cytokine-activated immunotherapy for malignant lymphoma at the stage of minimal residual disease after autologous stem cell transplantationR Or, A Ackerstein, A Nagler, et al.
Bone Marrow Transplantation|September 4, 2003
A new minimally ablative stem cell transplantation procedure in high-risk patients not eligible for nonmyeloablative allogeneic bone marrow transplantationM Y Shapira, R Or, I B Resnick, et al.
Clinical Transplantation|April 28, 2004
Tube thoracostomy during allogeneic stem cell transplantation does not carry an increased risk for infections or bleedingD Barkan, S Nusair, I B Resnick, et al.
Bone Marrow Transplantation|December 1, 2009
The number of infused CD34+ cells does not influence the incidence of GVHD or the outcome of allogeneic PBSC transplantation, using reduced-intensity conditioning and antithymocyte globulinP Tsirigotis, M Y Shapira, R Or, et al.
Bone Marrow Transplantation|April 3, 2001
Lack of known hepatitis virus in hepatitis-associated aplastic anemia and outcome after bone marrow transplantationR Safadi, R Or, Y Ilan, et al.
Bone Marrow Transplantation|March 7, 2006
A prospective, double-blind phase II study evaluating the safety and efficacy of a topical histamine gel for the prophylaxis of oral mucositis in patients post hematopoietic stem cell transplantationS Elad, A Ackerstein, M Bitan, et al.
Bone Marrow Transplantation|June 9, 2009
Quantitative monitoring of multi-donor chimerism: a systematic, validated framework for routine analysisD Kristt, B Gesundheit, J Stein, et al.
Acta Haematologica|March 7, 1998
Use of fiberoptic bronchoscopy in bone marrow transplant recipientsM Glazer, R Breuer, N Berkman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 13, 2006
Safety and efficacy of donor lymphocyte infusions following mismatched stem cell transplantationR Or, E Hadar, M Bitan, et al.
Pageof 26